Skip to main content

UNITED THERAPEUTICS Corp

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

UTHR$588.61+1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Comprehensive Income

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
(Unaudited) · (Unaudited)
Net income$333.0$309.5$607.9$631.7
Other comprehensive income:
Defined benefit pension plan:
Actuarial gain (loss) arising during period, net of tax——0.1(2.8)
Actuarial gain and prior service cost included in net periodic pension cost, net of tax(0.1)(0.4)(0.3)(0.8)
Total defined benefit pension plan, net of tax(0.1)(0.4)(0.2)(3.6)
Available-for-sale debt securities:
Unrealized (loss) gain arising during period, net of tax(5.9)2.2(15.1)7.6
Realized gain included in net income, net of tax—(0.6)(1.8)(0.6)
Total (loss) gain on available-for-sale debt securities, net of tax(5.9)1.6(16.9)7.0
Other comprehensive (loss) income, net of tax(6.0)1.2(17.1)3.4
Comprehensive income$327.0$310.7$590.8$635.1

During thethree and sixmonths ended June 30, 2026, the tax (benefit) expense in other comprehensive income waszero for the defined benefit pension plan and $(1.9) million and $(5.4) million, respectively, for the available-for-sale debt securities.

During thethree and sixmonths ended June 30, 2025, the tax (benefit) expense in other comprehensive income was $(0.1) million for the defined benefit pension plan and $0.5 million and $2.2 million, respectively, for the available-for-sale debt securities.

Quarterly Report5
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.